PWC News
Tuesday, May 13, 2025
No Result
View All Result
  • Home
  • Business
  • Economy
  • ESG Business
  • Markets
  • Investing
  • Energy
  • Cryptocurrency
  • Market Analysis
  • Home
  • Business
  • Economy
  • ESG Business
  • Markets
  • Investing
  • Energy
  • Cryptocurrency
  • Market Analysis
No Result
View All Result
PWC News
No Result
View All Result

1 Stock to Buy, 1 Stock to Sell This Week: Meta Platforms, Pfizer | Investing.com

Home Market Analysis
Share on FacebookShare on Twitter


• Tariff headlines, ‘Magazine 7’ earnings, U.S. jobs report, and PCE inflation knowledge might be in focus this week.

• Meta is predicted to report better-than-feared earnings attributable to an bettering digital advert market, making it an interesting inventory to purchase.

• Pfizer’s anticipated earnings dive and gross sales decline recommend a extra cautious method.

• Searching for extra actionable commerce concepts? Subscribe right here for 50% off InvestingPro!

The inventory market ended larger on Friday, with the foremost averages registering sharp positive factors for the week pushed by hopes for a de-escalation of the U.S.- China commerce battle.

The rose 2.5% for the week, the jumped 4.6%, whereas the tech-heavy soared 6.7%.

Supply: Investing.com

Extra volatility could possibly be in retailer this week as traders proceed to evaluate the outlook for the economic system, inflation, rates of interest and company earnings amid President Donald Trump’s commerce battle.

Wall Avenue’s first quarter earnings season hits full swing, with 4 of the huge ‘Magnificent Seven’ tech shares set to report their newest outcomes. Microsoft (NASDAQ:) and Meta Platforms (NASDAQ:) report on Wednesday evening, whereas Apple (NASDAQ:) and Amazon (NASDAQ:) are due late Thursday.

Different high-profile corporations on the agenda embody Qualcomm (NASDAQ:), ExxonMobil (NYSE:), Chevron (NYSE:), Eli Lilly (NYSE:), Pfizer (NYSE:), Coca-Cola (NYSE:), McDonald’s (NYSE:), Starbucks (NASDAQ:), United Parcel Service (NYSE:), Caterpillar (NYSE:), Robinhood (NASDAQ:), PayPal (NASDAQ:), Visa (NYSE:), and Mastercard (NYSE:).

In the meantime, most essential on the financial calendar might be Friday’s U.S. employment report, which is forecast to indicate the economic system added 129,000 positions in April. The unemployment price is seen holding regular at 4.2%.

Supply: Investing.com

Moreover the month-to-month jobs report, there may be additionally essential first-quarter GDP knowledge, in addition to the core PCE worth index, which is the Fed’s favourite inflation gauge.

No matter which route the market goes, beneath I spotlight one inventory more likely to be in demand and one other which may see recent draw back. Bear in mind although, my timeframe is simply for the week forward, Monday, April 28 – Friday, Might 2.

Inventory To Purchase: Meta Platforms

Meta Platforms appears positioned for a robust displaying when it experiences Q1 earnings this Wednesday after the shut at 4:40PM ET. CEO Mark Zuckerberg and CFO Susan Li are scheduled to debate the outcomes throughout a 5:00PM ET earnings name.

The bettering digital promoting market, coupled with Meta’s ongoing investments in AI and its large consumer base throughout platforms like Fb, Instagram, Threads, Reels, and WhatsApp, recommend the social media large might ship outcomes that exceed tempered expectations.

Market members foresee a large swing in META inventory after the print drops, with a doable implied transfer of 8.3% in both route.

Supply: InvestingPro

Whereas Meta’s development has decelerated in latest quarters, analysts challenge a strong 13% year-over-year income improve to $41.3 billion, accompanied by an 11% rise in adjusted earnings per share to $5.20.

Regardless of broader market volatility and considerations over diminished advert spend from Chinese language e-commerce corporations attributable to escalating U.S.-China commerce tensions, Meta’s diversified income streams and increasing international consumer base present a buffer.

Furthermore, Meta’s strategic investments in synthetic intelligence, together with new state-of-the-art knowledge facilities, place it nicely for long-term development.

It is usually value noting that Meta will maintain its preliminary ‘LlamaCon’ occasion on Tuesday, at which it’s anticipated to spotlight open-source developments by means of its Llama household of generative AI fashions.

Supply: Investing.com

META inventory ended Friday’s session at $547.27, about 26% beneath its all-time excessive reached in mid-February. At present ranges, the Menlo Park, California-based tech behemoth has a market cap of $1.38 trillion, making it the sixth most dear firm on the U.S. inventory change.

As InvestingPro factors out, Meta boasts a “GREAT” Monetary Well being General Rating of three.22, with significantly robust metrics in Revenue (4.49) and Money Movement (3.74). Analysts are overwhelmingly bullish on Meta, with a Sturdy Purchase consensus advice (1.48) and a imply worth goal of $713.63, suggesting upside potential of 30.4% from present ranges.

Be sure you try InvestingPro to remain in sync with the market development and what it means to your buying and selling. Subscribe now and place your portfolio one step forward of everybody else!

Inventory to Promote: Pfizer

On the other finish of the spectrum, Pfizer, the pharmaceutical large, is bracing for the discharge of its Q1 monetary outcomes on Tuesday at 6:45AM ET. The ‘Large Pharma’ firm is grappling with a number of headwinds, together with declining demand for its COVID-19 merchandise and elevated competitors in its non-COVID portfolio.

Moreover, Pfizer’s latest choice to desert one other weight problems drug improvement program underscores the challenges it faces in replenishing its product pipeline and sustaining long-term development.

Market members anticipate a doable implied transfer of 4% in both route in PFE inventory after the print drops.

Supply: InvestingPro

Analysts challenge a big drop in earnings, with EPS anticipated to fall over 18% to $0.69 per share, and income anticipated to lower by roughly 6% to $14.1 billion.

This pessimistic outlook is essentially as a result of expiration of the Diovan patent, a discount in Rasilez/Titrandet demand, and elevated competitors within the ALTITUDE medical examine.

With restricted near-term catalysts to offset these pressures, Pfizer’s inventory may face additional promoting strain post-earnings. Whereas its dividend yield stays enticing at present worth ranges, Pfizer’s near-term development prospects have dimmed significantly.

Supply: Investing.com

PFE inventory –which fell beneath $21 for the primary time since July 2012 earlier this month– closed at $22.92 on Friday. At present valuations, Pfizer has a market cap of $130 billion. Shares, that are buying and selling beneath their key shifting averages, are down 13.6% in 2025.

As per InvestingPro, Pfizer maintains a “GOOD” Monetary Well being General Rating of two.86, with its strongest part being Revenue (3.71), adopted by Money Movement (2.80) and Worth Momentum (2.77). Progress is its weakest space at 2.03.

Whether or not you’re a novice investor or a seasoned dealer, leveraging InvestingPro can unlock a world of funding alternatives whereas minimizing dangers amid the difficult market backdrop.

Subscribe now and immediately unlock entry to a number of market-beating options, together with:

• ProPicks AI: AI-selected inventory winners with confirmed observe document.

• InvestingPro Truthful Worth: Immediately discover out if a inventory is underpriced or overvalued.

• Superior Inventory Screener: Seek for the perfect shares primarily based on lots of of chosen filters, and standards.

• Prime Concepts: See what shares billionaire traders reminiscent of Warren Buffett, Michael Burry, and George Soros are shopping for.

Disclosure: On the time of writing, I’m lengthy on the S&P 500, and the by way of the SPDR® S&P 500 ETF (SPY), and the Invesco QQQ Belief ETF (QQQ). I’m additionally lengthy on the Invesco Prime QQQ ETF (QBIG), and Invesco S&P 500 Equal Weight ETF (RSP).

I often rebalance my portfolio of particular person shares and ETFs primarily based on ongoing danger evaluation of each the macroeconomic atmosphere and firms’ financials.

The views mentioned on this article are solely the opinion of the creator and shouldn’t be taken as funding recommendation.

Observe Jesse Cohen on X/Twitter @JesseCohenInv for extra inventory market evaluation and perception.





Source link

Tags: BuyInvesting.comMetaPfizerPlatformsSellstockWeek
Previous Post

India may seek parity with US on tech access in bilateral trade pact talks: Sources

Next Post

‘Strong Growth And Stability’: RBI Governor Sanjay Malhotra Asks US Industry To Invest In India

Related Posts

S3NS Summit Highlights Sovereignty And Trusted Cloud Progress
Market Analysis

S3NS Summit Highlights Sovereignty And Trusted Cloud Progress

May 13, 2025
Gold Prices Drop as Geopolitical Tensions Ease Amid US-China Trade Deal | Investing.com
Market Analysis

Gold Prices Drop as Geopolitical Tensions Ease Amid US-China Trade Deal | Investing.com

May 13, 2025
EUR/USD Bears Regain Control as US Dollar Rallies on US-China Trade Optimism | Investing.com
Market Analysis

EUR/USD Bears Regain Control as US Dollar Rallies on US-China Trade Optimism | Investing.com

May 13, 2025
1 Stock to Buy, 1 Stock to Sell This Week: Alibaba, Walmart | Investing.com
Market Analysis

1 Stock to Buy, 1 Stock to Sell This Week: Alibaba, Walmart | Investing.com

May 12, 2025
Cybersecurity in Banking: Fortifying Finances in the Digital Age by Securing Transactions and Ensuring Trust
Market Analysis

Cybersecurity in Banking: Fortifying Finances in the Digital Age by Securing Transactions and Ensuring Trust

May 11, 2025
Bitcoin Outperforms Gold, but the Yellow Metal Holds the Long-Term Value Advantage | Investing.com
Market Analysis

Bitcoin Outperforms Gold, but the Yellow Metal Holds the Long-Term Value Advantage | Investing.com

May 10, 2025
Next Post
‘Strong Growth And Stability’: RBI Governor Sanjay Malhotra Asks US Industry To Invest In India

'Strong Growth And Stability': RBI Governor Sanjay Malhotra Asks US Industry To Invest In India

Top Wall Street analysts pick these stocks for robust growth potential

Top Wall Street analysts pick these stocks for robust growth potential

Ghana’s Central Bank to Regulate Crypto by September 2025 – News Bytes Bitcoin News

Ghana's Central Bank to Regulate Crypto by September 2025 – News Bytes Bitcoin News

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

RECOMMENDED

TORM plc 2025 Q1 – Results – Earnings Call Presentation (NASDAQ:TRMD)
Business

TORM plc 2025 Q1 – Results – Earnings Call Presentation (NASDAQ:TRMD)

by PWC
May 11, 2025
0

Q1: 2025-05-08 Earnings AbstractEPS of - misses by $0.62  | Income of - misses by $241.32MThis text was written byComply withLooking...

How crypto market makers impact prices and market?

How crypto market makers impact prices and market?

May 13, 2025
S3NS Summit Highlights Sovereignty And Trusted Cloud Progress

S3NS Summit Highlights Sovereignty And Trusted Cloud Progress

May 13, 2025
We Are Held Hostage By The Titles We Crave

We Are Held Hostage By The Titles We Crave

May 12, 2025
Is the Housing Market Actually “Healthy”? Here’s My Scorecard to Find Out

Is the Housing Market Actually “Healthy”? Here’s My Scorecard to Find Out

May 11, 2025
There’s a Reason Trump Got Re-elected, But This Isn’t It – 2GreenEnergy.com

There’s a Reason Trump Got Re-elected, But This Isn’t It – 2GreenEnergy.com

May 7, 2025
PWC News

Copyright © 2024 PWC.

Your Trusted Source for ESG, Corporate, and Financial Insights

  • About Us
  • Advertise with Us
  • Disclaimer
  • Privacy Policy
  • DMCA
  • Cookie Privacy Policy
  • Terms and Conditions
  • Contact Us

Follow Us

No Result
View All Result
  • Home
  • Business
  • Economy
  • ESG Business
  • Markets
  • Investing
  • Energy
  • Cryptocurrency
  • Market Analysis

Copyright © 2024 PWC.